QuestionSBA
QuestionChoice
Furosemide has been shown to lead to some haematological adverse effects such as agranulocytosis and aplastic anaemia, however, a full blood count has little efficacy in demonstrating the beneficial symptomatic effects of furosemide.
50185
e
Full Blood Count daily
QuestionChoice
NT-proBNP is a hormone secreted by cardiomyocytes in response to stretching as a result of increased ventricular blood volume, it is therefore used diagnostically in cardiac failure. NT-proBNP is of little value in monitoring the symptomatic benefits of furosemide.
50182
b
NT-ProBNP after 1 week
QuestionChoice
Echocardiograms are used in the diagnostic and prognostic monitoring of cardiac failure, however, it has little value in monitoring the symptomatic benefits of furosemide.
50183
c
Echocardiogram after 1 week
QuestionChoice
Furosemide is a loop diuretic used in the symptomatic treatment of cardiac failure. Daily weights are an effective way to measure the effectiveness of furosemide by quantifying fluid losses.
50181
a
Daily weight measurements
QuestionChoice
Urea and Electrolytes (U&Es) should be monitored during furosemide therapy as furosemide can lead to electrolyte imbalance and AKI. However, U&Es have little efficacy in demonstrating the symptomatic benefits of Furosemide.
50184
d
Urea and Electrolytes daily
QuestionComment
doesn't say in the bnf
59633
QuestionComment
have you ever been to a ward like at all?
60778
User
subscriber
Ortho bro
User
subscriber
Hypertension Kinase
Concept
Chapter
#### Monitoring

The BNF advises to monitor lung function (in patients with a history of obstructive airway disease).

#### Overdoses

Overdosages with beta-blockers may cause cardiac effects such as bradycardia, hypotension, syncope, conduction abnormalities, and heart failure. Bradycardia is the most common arrhythmia, but some beta-blockers may induce ventricular tachyarrhythmias secondary to prolongation of QT interval (e.g. sotalol) or QRS duration (e.g. propranolol).
Non-cardiovascular effects include central nervous system effects (including drowsiness, confusion, convulsions, hallucinations, and in severe cases coma), respiratory depression, and bronchospasm.

Management
 - Airway protection 
 - Activated charcoal within 1 hour
 - IV Fluids
 
IV glucagon is the first-line management.
 
For symptomatic bradycardia, IV atropine may be used.

2618
2735
Acute pulmonary oedema - furosemide for symptomatic relief
Topic
9
Internal Medicine
10084
Case Presentation:  A 72-year-old female patient is admitted to the acute medical ward with breathlessness. She is due to commence treatment on Furosemide for congestive cardiac failure. Weight 72kg.


**PMH**
Myocardial infarction
Type 2 diabetes mellitus

**DH**

* Atorvastatin, 40mg nightly
* Clopidogrel, 75mg OD
* Bisoprolol, 5mg OD
* Ramipril, 7.5mg OD
* Metformin, 500mg BD

Question: Which of the following is the most appropriate monitoring of the beneficial effects of Furosemide therapy?
a